Prophase Labs Stock Market Value
| PRPH Stock | USD 0.75 0.01 1.35% |
| Symbol | ProPhase |
ProPhase Labs Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProPhase Labs. If investors know ProPhase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProPhase Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share (1.53) | Revenue Per Share 0.996 | Quarterly Revenue Growth (0.81) | Return On Assets (0.23) |
The market value of ProPhase Labs is measured differently than its book value, which is the value of ProPhase that is recorded on the company's balance sheet. Investors also form their own opinion of ProPhase Labs' value that differs from its market value or its book value, called intrinsic value, which is ProPhase Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProPhase Labs' market value can be influenced by many factors that don't directly affect ProPhase Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProPhase Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProPhase Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProPhase Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ProPhase Labs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ProPhase Labs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ProPhase Labs.
| 12/07/2022 |
| 11/26/2024 |
If you would invest 0.00 in ProPhase Labs on December 7, 2022 and sell it all today you would earn a total of 0.00 from holding ProPhase Labs or generate 0.0% return on investment in ProPhase Labs over 720 days. ProPhase Labs is related to or competes with Star Equity, Enzo Biochem, Neuronetics, Intelligent Bio, Biodesix, Precipio, and DarioHealth Corp. ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the cou... More
ProPhase Labs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ProPhase Labs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ProPhase Labs upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 57.54 | |||
| Value At Risk | (7.56) | |||
| Potential Upside | 8.07 |
ProPhase Labs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ProPhase Labs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ProPhase Labs' standard deviation. In reality, there are many statistical measures that can use ProPhase Labs historical prices to predict the future ProPhase Labs' volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (1.50) | |||
| Total Risk Alpha | (2.78) | |||
| Treynor Ratio | 2.69 |
ProPhase Labs Backtested Returns
ProPhase Labs maintains Sharpe Ratio (i.e., Efficiency) of -0.18, which implies the firm had a -0.18% return per unit of risk over the last 3 months. ProPhase Labs exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ProPhase Labs' Variance of 60.14, risk adjusted performance of (0.14), and Coefficient Of Variation of (496.34) to confirm the risk estimate we provide. The company holds a Beta of -0.58, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning ProPhase Labs are expected to decrease at a much lower rate. During the bear market, ProPhase Labs is likely to outperform the market. At this point, ProPhase Labs has a negative expected return of -1.38%. Please make sure to check ProPhase Labs' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if ProPhase Labs performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.82 |
Very good predictability
ProPhase Labs has very good predictability. Overlapping area represents the amount of predictability between ProPhase Labs time series from 7th of December 2022 to 2nd of December 2023 and 2nd of December 2023 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ProPhase Labs price movement. The serial correlation of 0.82 indicates that around 82.0% of current ProPhase Labs price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.82 | |
| Spearman Rank Test | 0.73 | |
| Residual Average | 0.0 | |
| Price Variance | 2.18 |
ProPhase Labs lagged returns against current returns
Autocorrelation, which is ProPhase Labs stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ProPhase Labs' stock expected returns. We can calculate the autocorrelation of ProPhase Labs returns to help us make a trade decision. For example, suppose you find that ProPhase Labs has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ProPhase Labs regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ProPhase Labs stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ProPhase Labs stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ProPhase Labs stock over time.
Current vs Lagged Prices |
| Timeline |
ProPhase Labs Lagged Returns
When evaluating ProPhase Labs' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ProPhase Labs stock have on its future price. ProPhase Labs autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ProPhase Labs autocorrelation shows the relationship between ProPhase Labs stock current value and its past values and can show if there is a momentum factor associated with investing in ProPhase Labs.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether ProPhase Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ProPhase Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prophase Labs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prophase Labs Stock:Check out ProPhase Labs Correlation, ProPhase Labs Volatility and ProPhase Labs Alpha and Beta module to complement your research on ProPhase Labs. For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
ProPhase Labs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.